Insider Trading & Ownership - BATE KENNETH

Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for BATE KENNETH

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2023-06-15
Option Award
2023-06-20
6:41 pm
N/A
N/A
MADRIGAL PHARMACEUTICALS INC.MDGLBATE KENNETH
Director
1,198$01,198
(Direct)
View
2023-06-02
Option Award
2023-06-06
08:00 am
N/A
2033-06-01
Astria Therapeutics Inc.ATXSBATE KENNETH
Director
14,100$014,100
(Direct)
View
2023-01-19
Disposition
2023-01-19
5:19 pm
N/A
N/A
AVEO PHARMACEUTICALS INC.AVEOBATE KENNETH
Director
375$15375
(Direct)
View
2023-01-19
Disposition
2023-01-19
5:19 pm
N/A
2023-05-29
AVEO PHARMACEUTICALS INC.AVEOBATE KENNETH
Director
68,202$0375
(Direct)
View
2022-08-12
Disposition
2022-08-16
6:55 pm
N/A
N/A
Epizyme Inc.EPZMBATE KENNETH
Director
17,054$00
(Direct)
View
2022-06-09
Option Award(A)
2022-06-21
08:33 am
N/A
2032-06-08
Astria Therapeutics Inc.ATXSBATE KENNETH
Director
8,333$08,333
(Direct)
View
2022-06-16
Option Award
2022-06-21
06:30 am
N/A
2025-06-16
MADRIGAL PHARMACEUTICALS INC.MDGLBATE KENNETH
Director
9,470$09,470
(Direct)
View
2022-06-09
Option Award
2022-06-09
6:00 pm
N/A
2032-06-08
Astria Therapeutics Inc.ATXSBATE KENNETH
Director
8,333$08,333
(Direct)
View
2022-06-07
Option Award
2022-06-08
4:58 pm
N/A
2032-06-06
AVEO PHARMACEUTICALS INC.AVEOBATE KENNETH
Director
22,500$022,500
(Direct)
View
2022-05-17
Option Award
2022-05-19
4:30 pm
N/A
2032-05-16
Epizyme Inc.EPZMBATE KENNETH
Director
50,000$058,060
(Direct)
View
2021-07-01
Option Award
2021-07-02
11:54 am
2022-07-01
2031-07-01
GENOCEA BIOSCIENCES INC.GNCABATE KENNETH
Director
15,000$015,000
(Direct)
View
2021-06-17
Option Award
2021-06-21
08:02 am
N/A
2024-06-17
MADRIGAL PHARMACEUTICALS INC.MDGLBATE KENNETH
Director
12,489$012,489
(Direct)
View
2021-06-11
Option Award
2021-06-15
4:41 pm
N/A
2031-06-10
Epizyme Inc.EPZMBATE KENNETH
Director
48,619$048,619
(Direct)
View
2021-06-09
Option Award
2021-06-09
5:17 pm
N/A
2031-06-08
AVEO PHARMACEUTICALS INC.AVEOBATE KENNETH
Director
12,500$012,500
(Direct)
View
2021-06-02
Option Award
2021-06-02
7:16 pm
N/A
2031-06-01
CATABASIS PHARMACEUTICALS INCCATBBATE KENNETH
Director
100,000$0100,000
(Direct)
View
2020-06-10
Option Award
2020-06-30
4:34 pm
N/A
2030-06-09
AVEO PHARMACEUTICALS INC.AVEOBATE KENNETH
Director
4,000$04,000
(Direct)
View
2020-06-18
Option Award
2020-06-19
4:12 pm
2021-06-18
2030-06-18
GENOCEA BIOSCIENCES INC.GNCABATE KENNETH
Director
15,000$015,000
(Direct)
View
2020-06-17
Option Award
2020-06-18
07:46 am
N/A
2025-06-17
MADRIGAL PHARMACEUTICALS INC.MDGLBATE KENNETH
Director
6,000$06,000
(Direct)
View
2020-06-11
Option Award
2020-06-12
11:44 am
N/A
2030-06-10
CATABASIS PHARMACEUTICALS INCCATBBATE KENNETH
Director
7,500$07,500
(Direct)
View
2020-05-29
Option Award
2020-06-02
4:15 pm
N/A
2030-05-28
Epizyme Inc.EPZMBATE KENNETH
Director
14,013$014,013
(Direct)
View
2019-07-18
Option Award
2019-07-19
4:03 pm
2020-07-18
2029-07-18
GENOCEA BIOSCIENCES INC.GNCABATE KENNETH
Director
5,625$05,625
(Direct)
View
2019-06-27
Option Award
2019-07-01
5:58 pm
N/A
2024-06-27
MADRIGAL PHARMACEUTICALS INC.MDGLBATE KENNETH
Director
10,000$010,000
(Direct)
View
2019-06-12
Option Award
2019-06-13
5:01 pm
N/A
2029-06-11
AVEO PHARMACEUTICALS INCAVEOBATE KENNETH
Director
40,000$040,000
(Direct)
View
2019-05-31
Option Award
2019-06-07
4:28 pm
N/A
2029-05-30
Epizyme Inc.EPZMBATE KENNETH
Director
17,633$017,633
(Direct)
View
2019-06-04
Option Award
2019-06-05
4:05 pm
N/A
2029-06-03
CATABASIS PHARMACEUTICALS INCCATBBATE KENNETH
Director
7,500$07,500
(Direct)
View
(A) Indicate amendment filing.